Journals / Haseki Tıp Bülteni / 2014 / Cilt: 52 - Sayı: 2

HPV DNA Positivity Rate and Evaluation of Cytopatological Results in Patients with Chronic Vaginal Discharge

Kronik Vajinal Akıntılı Hastalarda HPV-DNA Pozitiflik Oranı ve Sitopatolojik Sonuçların Değerlendirilmesi

Pages
93–97
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no statistically significant difference in cervical cytological abnormalities and CIN between HPV-DNA positive and negative groups.Conclusion: In our study, the rates of HPV DNA positivity and abnormal cytopathological results among patients with chronic vaginal discharge were found to be higher than that reported in the literature

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: There are new publications stating that chronic infection may facilitate dysplastic changes and persistence of human papillomavirus (HPV)-DNA positivity.
📊
Key Findings & Data:Frequency of this coincidence and cervical cytological and pathological examination results were investigated in patients with chronic vaginal discharge.Methods: One hundred three patients, who were treated at least 3 times for chronic mucopurulent discharge with accessible HPV DNA results, were analyzed retrospectively.
💡
Conclusion & Impact:There was no statistically significant difference in cervical cytological abnormalities and CIN between HPV-DNA positive and negative groups.Conclusion: In our study, the rates of HPV DNA positivity and abnormal cytopathological results among patients with chronic vaginal discharge were found to be higher than that reported in the literature
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: There are new publications stating that chronic infection may facilitate dysplastic changes and persistence of human papillomavirus (HPV)-DNA positivity. Frequency of this coincidence and cervical cytological and pathological examination results were investigated in patients with chronic vaginal discharge.Methods: One hundred three patients, who were treated at least 3 times for chronic mucopurulent discharge with accessible HPV DNA results, were analyzed retrospectively. Risk factors were identified for HPV DNA positivity. HPV DNA positive-patients were divided into two groups (positive and negative) according to the presence and absence of HPV DNA. The results of cytopatological and histopathological examinations and risk factors were compared between the two groups.Results: The mean age of the patients was 35±9 years. Sixty-four percent of the patients were positive for HPV DNA. Of the HPV DNA positive patients, 41% had abnormal cytological findings, 16% had cervical intraepithelial neoplasia (CIN). Of the HPV DNAnegative patients, 16% had abnormal cytological findings and, 2 patients had CIN. There was no statistically significant difference in cervical cytological abnormalities and CIN between HPV-DNA positive and negative groups.Conclusion: In our study, the rates of HPV DNA positivity and abnormal cytopathological results among patients with chronic vaginal discharge were found to be higher than that reported in the literature

Özet

Amaç: Kronik enfeksiyonun HPV-DNA persistansı ve displazik değişimleri kolaylaştırdığı yönünde yeni yayınlar mevcuttur. Kronik vajinal akıntılı hastalarda bu beraberliğin sıklığı, servikal sitolojik ve histopatolojik inceleme sonuçları araştırıldı. Yöntemler: Kronik mukopürülan akıntı nedeniyle en az üç kez vajinit tedavisi görmüş, HPV DNA'sına ulaşılan 103 hasta retrospektif olarak incelendi. HPV DNA pozitifliği için risk faktörleri değerlendirildi. Hastalar HPV DNA varlığı ve yokluğuna göre iki gruba ayrıldı (HPV DNA pozitif ve negatif). Sitopatolojik ve histopatolojik inceleme sonuçları ve risk faktörleri bu iki grup arasında karşılaştırıldı. Bulgular: Hastaların yaş ortalaması 35±9 idi. Yüzde 64 hastada HPV-DNA pozitifti. HPV-DNA'sı pozitif olan hastaların %41'inde anormal sitolojik bulgular, %16'sında CIN saptandı. HPV-DNA'sı negatif grubun %16'sında anormal sitolojik bulgular saptanırken, ikisinde CIN saptandı. HPV-DNA pozitif ve negatif gruplar arasında servikal sitolojik anormallik ve CIN saptanması açısından istatistiksel olarak anlamlı fark saptanmadı. Sonuç: Çalışmamızda kronik mukopürülan akıntılı hastalarda HPV DNA pozitifliği ve anormal sitolojik ve histolojik bulguları genel literatüre göre daha yüksek oranda saptadık

🔖

Cite This Article

ATEŞER, G., AYDIN, D. S., GÜNVER, F., PURİSA, S. (2014). HPV DNA Positivity Rate and Evaluation of Cytopatological Results in Patients with Chronic Vaginal Discharge. Haseki Tıp Bülteni, Cilt: 52 - Sayı: 2, 93–97. https://ajindex.com/articles/267904

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. zur Hausen H. Papıllomavıruses and cancer: from basic studies to clinical applıcatıon. Nat Rev Cancer 2002;2:342-50. de Villiers EM1, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of Papillomaviruses. Virology 2004;324:17-27. zur Hausen H. Papillomavirus Infections-A Major Cause of Human Cancers. Biochim Biophys Acta 1996;1288:F55-78. Hassen E, Chaieb A, Letaief M, et al. Cervical human papillomavirus infection in tunisian women. Infection 2003;31:143-8.
  2. Saslow D, Runowicz CD, Solomon D, et al. American cancer society guideline for the early detection of cervical neoplasia and cancer. Ca Cancer J Clin 2002;52:342-62. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer InstMonogr 2003;31:3-13. Castle PE. Beyond human papillomavirus: the cervix, exogenous secondary factors and the development of cervical precancer, and cancer. J Low Genit Tract Dis 2004;8:224-30.
  3. Castle PE, Escoffery C, Schachter J, et al: Chlamydia Trachomatis, Herpes Simplex Virus 2, And Human T-Cell Lymphotrophic Virus Type 1 Are Not Associated With Grade of Cervical Neoplasia in Jamaican Colposcopy Patients. Sex Transm Dis 2003;30:575-80. Szostek S1, Zawilinska B, Kopec J, Kosz-Vnenchak M. Herpes viruses as possible cofactors in HPV-16-related oncogenesis. Acta Biochim Pol 2009;56:337-42.
  4. Kwalniewska A, Korobowicz E, Zdunek M, et al. Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples. European journal of gynaecological oncology. Eur J Gynaecol Oncol 2009;30:65-70.
  5. Qian YS, Lv W, Sui LH, Wang J. Study on the relationship between genesis and development of cervical cancer and the infection of human papillomavirus type 16/18, human herpesvirus II and cytomegalovirus. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26:622-5.
  6. Giuliano AR, Sedjo RL, Roe DJ, et al. Clearance of Oncogenic Human Papillomavirus (Hpv) İnfection: Effect of Smoking (United States). Cancer Causes Control 2002;13:839-46. Severson J1, Evans TY, Lee P, Chan T, Arany I, Tyring SK. Human papillomavirus infections: epidemiology, pathogenesis, and therapy. J Cutan Med Surg 2001;5:43-60.
  7. Yetimalar H, Kasap B, Cukurova K, Yildiz A, Keklik A, Soylu F. Cofactors in Human Papillomavirus Infection and cervical carcinogenesis. Arch Gynecol Obstet 2012;285:805-10.
  8. Eroğlu C, Keşli R, Eryılmaz MA, ve ark. Serviks kanseri için riskli olan kadınlar